CD45RA and CCR7 expression patterns indicated that both LAP+ and LAP− subsets of Foxp3+CD4+ T cells mostly had an effector/memory phenotype in peripheral blood as well as in tumor sites of CRC patients (Fig. 2B) [17]. This evidence concerns the gene FOXP3 and neoplasm.